Cribstone Capital Management, LLC Abbott Laboratories Transaction History

Cribstone Capital Management, LLC

$169 Million
Q4 2022

A detailed history of Cribstone Capital Management, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Cribstone Capital Management, LLC holds 8,881 shares of ABT stock, worth $1.02 Million. This represents 0.58% of its overall portfolio holdings.

Number of Shares

8,881

Previous 8,658 2.58%

Holding current value

$1.02 Million

Previous $838,000 16.35%

% of portfolio

0.58%

Previous 0.52%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $21,198 - $24,868	223 Added 2.58%	8,881 $975,000
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $45,283 - $52,430	468 Added 5.71%	8,658 $838,000
Q2 2022 Aug 11, 2022	BUY	$102.07 - $123.37 $2,347 - $2,837	23 Added 0.28%	8,190 $890,000
Q1 2022 May 16, 2022	SELL	$114.02 - $139.04 $69,096 - $84,258	-606 Reduced 6.91%	8,167 $967,000
Q4 2021 Feb 10, 2022	BUY	$115.53 - $141.46 $9,242 - $11,316	80 Added 0.92%	8,773 $1.24 Million
Q3 2021 Nov 18, 2021	SELL	$116.66 - $129.06 $49,113 - $54,334	-421 Reduced 4.62%	8,693 $1.03 Million
Q2 2021 Aug 13, 2021	BUY	$105.79 - $124.53 $43,797 - $51,555	414 Added 4.76%	9,114 $1.06 Million
Q1 2021 Apr 23, 2021	BUY	$108.84 - $128.23 $207,231 - $244,149	1,904 Added 28.02%	8,700 $1.04 Million
Q4 2020 Feb 12, 2021	BUY	$105.0 - $114.42 $8,715 - $9,496	83 Added 1.24%	6,796 $744,000
Q3 2020 Nov 17, 2020	SELL	$91.64 - $111.29 $76,885 - $93,372	-839 Reduced 11.11%	6,713 $731,000
Q2 2020 Aug 03, 2020	BUY	$76.57 - $98.0 $35,987 - $46,060	470 Added 6.64%	7,552 $690,000
Q1 2020 Apr 21, 2020	SELL	$62.82 - $91.86 $13,757 - $20,117	-219 Reduced 3.0%	7,082 $559,000
Q4 2019 Jan 08, 2020	SELL	$78.51 - $87.4 $146,813 - $163,438	-1,870 Reduced 20.39%	7,301 $634,000
Q3 2019 Nov 20, 2019	SELL	$81.84 - $88.74 $110,402 - $119,710	-1,349 Reduced 12.82%	9,171 $767,000
Q2 2019 Jul 22, 2019	BUY	$72.88 - $85.0 $28,860 - $33,660	396 Added 3.91%	10,520 $885,000
Q1 2019 Apr 11, 2019	BUY	$66.22 - $80.06 $286,732 - $346,659	4,330 Added 74.73%	10,124 $809,000
Q4 2018 Feb 12, 2019	SELL	$65.56 - $74.27 $6,883 - $7,798	-105 Reduced 1.78%	5,794 $419,000
Q3 2018 Oct 25, 2018	BUY	$60.81 - $73.36 $1,520 - $1,834	25 Added 0.43%	5,899 $433,000
Q1 2018 Apr 19, 2018	BUY	$56.27 - $63.62 $41,245 - $46,633	733 Added 14.26%	5,874 $352,000
Q4 2017 Feb 02, 2018	SELL	$53.68 - $57.47 $5,529 - $5,919	-103 Reduced 1.96%	5,141 $293,000
Q3 2017 Oct 30, 2017	BUY	$48.06 - $53.64 $252,026 - $281,288	5,244	5,244 $280,000

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $201B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cribstone Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cribstone Capital Management, LLC with notifications on news.

Account

Cribstone Capital Management, LLC Abbott Laboratories Transaction History